Related Experiment Video
Updated: Aug 14, 2026

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
Published on: February 9, 2021
Oxygen-Embedded Fused-Ring Structure for NIR-Triggered Multimodal Phototherapy of Laryngeal Cancer
Hao Liu1,2, Bo Yu1, Shiwen Zhong1
1Department of Otorhinolaryngology, The Second Hospital of Dalian Medical University, Dalian116023, Liaoning, China.
Abstract:
Laryngeal cancer requires precise and minimally invasive therapeutic strategies to preserve critical physiological functions. Herein, an oxygen-embedded fused-ring organic semiconductor (COi8FIC) was reported, which is formulated into multifunctional nanoparticles for near-infrared (NIR)-triggered multimodal phototherapy. The incorporation of oxygen atoms into the conjugated backbone, together with fluorinated cyanoindanone end-groups, narrows the bandgap to 1.35 eV and enhances intramolecular charge transfer, thereby promoting non-radiative decay and intersystem crossing. As a result, COi8FIC nanoparticles exhibit a high photothermal conversion efficiency of 62% and generate multiple reactive oxygen species (•OH, O2-, and 1O2) via synergistic Type I and Type II photodynamic pathways. In vitro, the nanoparticles produce approximately 2.5-fold higher ROS levels than monotherapies. In vivo, NIR irradiation induces rapid hyperthermia (ΔT ca. 23.6 °C), resulting in a tumor growth inhibition rate of 93.3%. Tumor regression was observed in all treated mice, with complete tumor eradication in three of five mice and near-complete elimination in the remaining two, with no significant irreversible organ damage. These results highlight the potential of this system as a promising platform for multimodal phototherapy of laryngeal cancer.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Tumor Immunotherapy

